In recent years, there has been a growing focus on the importance of personalised, proactive care for those living with chronic inflammatory conditions. MedTech Actuator startup, InflaMed is at the forefront of this movement, prioritising proactive care using personalised data and insights to guide shared decision-making and improve care for those living with chronic conditions like allergies, eczema, and asthma.

In recent years, personalised and proactive care has become essential for people with chronic inflammatory conditions. InfláMed is at the forefront, using personalised data and patient-clinician insights to guide shared decisions for allergies, eczema and asthma.

The idea for InfláMed began when founders Mari Robert and Alan Robert's daughter experienced a severe eczema flare-up. As parents, Mari and Alan learned that relying on various chemicals was often expected and that reactive, one-size-fits-all care wasn't enough. Leveraging Mari's software-developer background, they created an app-enabled platform that records flare triggers, medication responses and symptom images. InfláMed's goal: serve a wider community with sophisticated capabilities and ongoing support.